Nova Nordisk
Nova Nordisk

WEBINAR: Novo Nordisk tumbles as competition heats up

Since the Biznews global share portfolio was launched it has produced annualised growth of 22 percent, helped along of course by the weakness of the Rand.
Published on

Every month Alec Hogg reviews the Biznews.com Global Share Portfolio. The portfolio is built on Warren Buffett foundations, and over the long term the market noise doesn't take away from the fact that all the stocks held, are well run companies. Alec takes us through the performance and current position of the portfolio, providing a comprehensive breakdown of how the shares are doing and how the companies, split between the likes of Apple, Amazon, Barclays, Berkshire Hathaway, Alphabet, IBM and Novo Nordisk are performing. – Stuart Lowman

Alec Hogg: Well hi there, sorry we're a little late today, a few little slight technical hitches but it's Alec Hogg coming to you from London and with the monthly update of our global share portfolio. Of course, we're getting to the end of September 2016. We actually launched the portfolio in September 2014. Then we had a little technical hitch, so we relaunched it again in December. In fact, we'd been doing quite well in those three months. The reason was we were expanding the size of the portfolio and we started then with R2m (around about just under $200 000). Since that period of time, the portfolio has improved or has grown, annualised by 22 percent a year, it's up by 38 percent in that period, helped along of course by the weakness of the Rand. With me today is our Managing Editor at BizNews, Stuart Lowman?

___STEADY_PAYWALL___

Loading content, please wait...

Related Stories

No stories found.
BizNews
www.biznews.com